Endocannabinoid signaling in female reproductive events: A potential therapeutic target?

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Nearly 30 years after the discovery in 1964 of the psychoactive ingredient of cannabis (Cannabis sativa), Δ9-tetrahydrocannabinol, its endogenous counterparts were discovered and collectively termed endocannabinoids (eCBs): N-arachidonoylethanolamine (anandamide) in 1992 and 2-arachidonoylglycerol in 1995. Since then, intense research has identified additional eCBs and an ensemble of proteins that bind, synthesize and degrade them, the so-called eCB system. Altogether, these new compounds have been recognized as key mediators of several aspects of human pathophysiology, and in particular of female fertility. Here, the main features of the eCB system are presented, in order to put in a better perspective the relevance of eCB signaling in virtually all steps of human reproduction and to highlight emerging hopes that elements of this system might indeed become novel targets to combat fertility problems.

Original languageEnglish
Pages (from-to)1423-1427
Number of pages5
JournalExpert Opinion on Therapeutic Targets
Volume19
Issue number11
DOIs
Publication statusPublished - Nov 2 2015

Fingerprint

Endocannabinoids
Cannabis
Fertility
Dronabinol
Reproduction
Therapeutics
Research
Proteins
2-arachidonylglycerol
anandamide
N-arachidonoylethanolamine

Keywords

  • immune regulation
  • implantation
  • oocyte maturation
  • oviductal transport
  • parturition
  • signaling pathways

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Endocannabinoid signaling in female reproductive events : A potential therapeutic target? / Maccarrone, Mauro.

In: Expert Opinion on Therapeutic Targets, Vol. 19, No. 11, 02.11.2015, p. 1423-1427.

Research output: Contribution to journalArticle

@article{8edfb0cbc7d44ca78621db3c377e66b9,
title = "Endocannabinoid signaling in female reproductive events: A potential therapeutic target?",
abstract = "Nearly 30 years after the discovery in 1964 of the psychoactive ingredient of cannabis (Cannabis sativa), Δ9-tetrahydrocannabinol, its endogenous counterparts were discovered and collectively termed endocannabinoids (eCBs): N-arachidonoylethanolamine (anandamide) in 1992 and 2-arachidonoylglycerol in 1995. Since then, intense research has identified additional eCBs and an ensemble of proteins that bind, synthesize and degrade them, the so-called eCB system. Altogether, these new compounds have been recognized as key mediators of several aspects of human pathophysiology, and in particular of female fertility. Here, the main features of the eCB system are presented, in order to put in a better perspective the relevance of eCB signaling in virtually all steps of human reproduction and to highlight emerging hopes that elements of this system might indeed become novel targets to combat fertility problems.",
keywords = "immune regulation, implantation, oocyte maturation, oviductal transport, parturition, signaling pathways",
author = "Mauro Maccarrone",
year = "2015",
month = "11",
day = "2",
doi = "10.1517/14728222.2015.1062878",
language = "English",
volume = "19",
pages = "1423--1427",
journal = "Expert Opinion on Therapeutic Targets",
issn = "1472-8222",
publisher = "Informa Healthcare",
number = "11",

}

TY - JOUR

T1 - Endocannabinoid signaling in female reproductive events

T2 - A potential therapeutic target?

AU - Maccarrone, Mauro

PY - 2015/11/2

Y1 - 2015/11/2

N2 - Nearly 30 years after the discovery in 1964 of the psychoactive ingredient of cannabis (Cannabis sativa), Δ9-tetrahydrocannabinol, its endogenous counterparts were discovered and collectively termed endocannabinoids (eCBs): N-arachidonoylethanolamine (anandamide) in 1992 and 2-arachidonoylglycerol in 1995. Since then, intense research has identified additional eCBs and an ensemble of proteins that bind, synthesize and degrade them, the so-called eCB system. Altogether, these new compounds have been recognized as key mediators of several aspects of human pathophysiology, and in particular of female fertility. Here, the main features of the eCB system are presented, in order to put in a better perspective the relevance of eCB signaling in virtually all steps of human reproduction and to highlight emerging hopes that elements of this system might indeed become novel targets to combat fertility problems.

AB - Nearly 30 years after the discovery in 1964 of the psychoactive ingredient of cannabis (Cannabis sativa), Δ9-tetrahydrocannabinol, its endogenous counterparts were discovered and collectively termed endocannabinoids (eCBs): N-arachidonoylethanolamine (anandamide) in 1992 and 2-arachidonoylglycerol in 1995. Since then, intense research has identified additional eCBs and an ensemble of proteins that bind, synthesize and degrade them, the so-called eCB system. Altogether, these new compounds have been recognized as key mediators of several aspects of human pathophysiology, and in particular of female fertility. Here, the main features of the eCB system are presented, in order to put in a better perspective the relevance of eCB signaling in virtually all steps of human reproduction and to highlight emerging hopes that elements of this system might indeed become novel targets to combat fertility problems.

KW - immune regulation

KW - implantation

KW - oocyte maturation

KW - oviductal transport

KW - parturition

KW - signaling pathways

UR - http://www.scopus.com/inward/record.url?scp=84946723237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84946723237&partnerID=8YFLogxK

U2 - 10.1517/14728222.2015.1062878

DO - 10.1517/14728222.2015.1062878

M3 - Article

C2 - 26126134

AN - SCOPUS:84946723237

VL - 19

SP - 1423

EP - 1427

JO - Expert Opinion on Therapeutic Targets

JF - Expert Opinion on Therapeutic Targets

SN - 1472-8222

IS - 11

ER -